Meredith Durkin Wolfe - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Meredith Durkin Wolfe's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Meredith Durkin Wolfe
Verified
Director of Research, BioCentury
Milwaukee
Beats
Politics , Brexit , Innovation Policy , NHS Health Policy , Science Policy
Content
By Meredith Durkin Wolfe Verified| BioCentury Verified DATA GRAPHICS | Data ByteXBI and NBI continue to fall more than broader markets By Meredith Durkin Wolfe, Director of ResearchStocks fell again Tuesday, as markets continue to react to tariff policy. The XBI and NBI have lost 17% and 14% since last Friday, March 28, and 11% and 10% since tariffs were announced Wednesday. Their slide outpaces the broader markets, with the S&P500 down 11% since last Friday and 8% since Wednesday.
By Meredith Durkin Wolfe Verified| BioCentury Verified DATA GRAPHICS | Data BytePreviously a bright spot in 2025 markets, Hong Kong stocks take a sharp downturn By Meredith Durkin Wolfe, Director of ResearchBiopharma stocks listed in Hong Kong fell Monday, following the trendsetting of the U.S. markets on Friday. Of 24 companies with drugs on the market and valuations over US$1 billion at Friday’s close, 17 performed worse that the 13% drop by the Hang Seng Index (HSI). The smallest loss in the group was 8%.
By Meredith Durkin Wolfe Verified| BioCentury Verified DATA GRAPHICS | Data ByteXBI and NBI continue to fall more than broader markets By Meredith Durkin Wolfe, Director of ResearchStocks fell again Tuesday, as markets continue to react to tariff policy. The XBI and NBI have lost 17% and 14% since last Friday, March 28, and 11% and 10% since tariffs were announced Wednesday. Their slide outpaces the broader markets, with the S&P500 down 11% since last Friday and 8% since Wednesday.
Company Info
BioCentury
BioCentury Inc. is a biotechnology-focused business intelligence and analytics company based in Redwood City, California. With over 30 years of experience, it specializes in providing strategic insights and data analysis tailored to the biopharma and biotech industries. The company reported a revenue of $16.2 million. BioCentury offers the BCIQ platform, which includes modules for tracking companies, products, and financial data. This platform helps clients identify trends, partnerships, and investment opportunities. Additionally, BioCentury provides analytical content that includes market trend analysis, visual data tools, and expert interviews. The company also facilitates networking through exclusive events and workshops, connecting C-suite executives and investors within the biopharma community.
'+1 650-595-5333
Founded: 1992